OBIO is a not-for-profit organization committed to the development of an integrated health innovation economy for the province. Its report, How Canada Should be Engaging in a $9 Trillion Dollar Health Economy, was based on surveys and interviews with 125 CEOs of health science companies around the country. It makes recommendations aimed to ensure Canadians get the economic and patient benefits from being competitive in the global health market.
OBIO Launches Report in the Nation’s Capital
OBIO comments on Canada's Innovation Agenda
Tuesday in a joint announcement the Minister of Innovation Science and Economic Development, Minister of Science, and the Minister of Small Business and Tourism unveiled 6 action areas to build an innovative Canada.
For OBIO's comments on report, click here.
PATHS TO THE FUTURE: HOW CANADA SHOULD BE ENGAGING IN A $9 TRILLION DOLLAR HEALTH ECONOMY VS. THE CANADIAN INNOVATION AGENDA
On Tuesday June 16, 2016 the first steps began towards the development of a Canadian National Inclusive Innovation Agenda. In a joint announcement the Minister of Innovation Science and Economic Development, Minister of Science, and the Minister of Small Business and Tourism unveiled 6 action areas to build an innovative Canada.
How Canada Should be Engaging in a $9 Trillion Dollar Health Economy
There are compelling reasons for a strong, Canadian healthcare industry. Canada has opportunities but there are barriers to success. This report presents industry’s solutions.
Federal Budget Misses Opportunity to Scale and Grow Health Science Companies
The 2016 Federal Liberal budget contains funding to support a much needed Innovation Agenda and promises to build globally competitive companies. At the same time the majority of this funding is directed to incubators and accelerators, granting councils and public institutions to support basic research. In order to compete in the $9 trillion global health science economy, Canada needs to devote financial resources to health science companies at the next stage of development by investing in scale up, job creation and revenue generation.
Click here to read the article online
OBIO Strategic Review: December 2015
An organization's ability to learn, and translate that learning into action rapidly, is the ultimate competitive advantage.
Jack Welch
As we come to the end of 2015, OBIO is proud of a year that has been characterized by recognition and support from our partners and sponsors, new learnings from the extensive feedback we received during our industry consultations and a very busy schedule as we delivered on programming and advocacy work.
Click here to read the article online
Gail Garland, OBIO CEO talks with BNN about Canada's health science industry
Gail Garland, OBIO CEO talks with BNN about the economic and health benefits that accrue to Canada by building a globally competitive Canadian health science industry. Click here for the full interview.
OBIO Globe & Mail Op-Ed: Canada needs a strategy to reach its biotech potential
OBIO® Strategic Review: August 2015
They always say time changes things, but you actually have to change them yourself.
Andy Warhol
2015 has been a year of growth and opportunity for OBIO with expanding networks and new partnerships. Since we released our five year strategic review in January 2015, there have been significant developments both within our walls and across the ecosystem.
OBIO / OBEST Five Year Strategic Review
“The best way to predict the future is to create it”
Peter Drucker
Since its founding in 2009, the Ontario Bioscience Innovation Organization (OBIO®) has been engaged in creating the future of Ontario’s biomedical sector through industry-led strategy, policy development, advocacy and high impact programming. OBIO pursues innovative thought leadership within a culture of trust, reaching out to ever growing circles of thinkers and stakeholders.
Biotechnology Focus article: OBIO® receives investment from the government of Canada to boost investment opportunities and strengthen innovation for Ontario’s commercial bioscience cluster
On May 22, 2015, Member of Parliament for Don Valley West John Carmichael, along with Member of Parliament for Etobicoke-Lakeshore Bernard Trottier announced an investment of up to $3.894 million to support the Ontario Bioscience Innovation Organization’s (OBIO®) efforts to boost investment opportunities for Ontario companies and strengthen innovation for Ontario’s
commercial bioscience cluster.
OBEST Strategic Implementation Plan
Over the past several months, OBESTTM has engaged >200 senior representatives from major stakeholder groups across Ontario’s life-sciences sector. The 6-month strategic planning process has resulted in defined priorities and a plan for robust growth and commercial viability of the province’s bioscience industry.